“robert-langer” Archives

in
Entry Author Date Location
StemBioSys Continues Expanding Distribution, Adding Western Europe 12/07/17 Texas
MIT’s The Engine, Now With $200M, Makes First Bets: 3 Takeaways 09/19/17 Boston
Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists 08/17/17 Boston
San Antonio Biomedical Group Awards Miami Healthcare Researcher 08/02/17 Texas
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment 04/13/17 Boston
StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells 03/01/17 Texas
StemBioSys Taps VWR to Distribute Stem Cell Products in U.S., Canada 01/19/17 Texas
Cancer Diagnostic Startup Capio Moves to Wisconsin, Raises $2.9M 01/05/17 Wisconsin
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
StemBioSys Takes In $2.7M, Signs New U.S. Distribution Deal 12/06/16 Texas
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
San Antonio’s StemBioSys Brings Product to South Korea With SeouLin 07/12/16 Texas
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
In First Distribution Deal, StemBioSys Teams with Funakoshi in Japan 06/01/16 Texas
Agenovir Gets $10.6M To Take on Viral Infections With CRISPR 05/18/16 San Francisco
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
PureTech’s Alivio Debuts With Drug-Delivery Gel for Inflammation 05/10/16 Boston
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
Bind Therapeutics Sheds Employees, Considers New Capital or Deals 04/06/16 Boston
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia 03/04/16 Texas
Pushing Past Preclinical, Arsenal and 480 Biomedical Land $26.5M 06/03/15 Boston
StemBioSys Takes $8M to Build Homes For Stem Cells 04/15/15 Texas
Kyoto Prize Winner Robert Langer on Innovations to Come 03/19/15 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Page 1 of 3 next page »